Previous 10 | Next 10 |
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today provided a preliminary 2021 year-end corporate update. Fourth Quarter Highl...
Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the 40th Annual J.P. Morgan Healthcare Conference. The Company ...
The Premium Portfolio has gained +6.80% YTD compared to the S&P 500 +21.62% YTD and the Aurum Hedge Fund Industry Index +6.31% with one week to go. The Premium Portfolio compound annual growth rate (CAGR) of +25.57% compares favorably to the S&P 500 of +14.31% CAGR from 2018. ...
Reliance Global (NASDAQ:RELI) +85%. Aridis Pharmaceuticals (NASDAQ:ARDS) +72% after its antibody cocktail retains effectiveness against Omicron variant. Quoin Pharmaceuticals (NASDAQ:QNRX) +44%. Cassava Sciences (NASDAQ:SAVA) +40% Cassava Sciences, Biofrontera rise amid so...
RZD Medicine is the second Russian hospital to initiate a Senhance Surgical System program Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided S...
Franklin Medical Center to become 4th Senhance Hospital in Louisiana Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today ...
Surgical Robots market will grow at a rapid pace (CAGR of 20.1%) in the future. ASXC's Senhance System and other products are achieving regulatory clearances from U.S., Europe, and Asian authorities. More hospitals are buying or leasing their robots, and I expect the revenue growt...
3 Biotech Penny Stocks to Watch in Mid-November 2021 Biotech penny stocks remain some of the most popular stocks of the past year and a half. While the pandemic highlighted the biotech industry at first, we are still seeing the effects of this over one year after it began. But, not all ...
Shares of Asensus Surgical (NYSEMKT: ASXC) , a manufacturer of robot-assisted surgical systems, are on the rise after the company released third-quarter earnings. Investors reacting to the highlights drove the stock 14.6% higher as of 10:38 a.m. EDT on Thursday. After markets cl...
Asensus Surgical, Inc. (ASXC) Q3 2021 Earnings Conference Call November 03, 2021 4:30 PM ET Company Participants Mark Klausner - Westwicke, Investor Relations Anthony Fernando - President & Chief Executive Officer Shameze Rampertab - Chief Financial Officer Conference Call Participants Sw...
News, Short Squeeze, Breakout and More Instantly...
Asensus Surgical Inc Com Company Name:
ASXC Stock Symbol:
NYSE Market:
Asensus Surgical Inc Com Website:
RESEARCH TRIANGLE PARK, N.C., July 24, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a global leader of innovative digital solutions for the operating room, announced that The Rocky Mountain Hospital for Children in Denver, Colorado, part of HCA Healthcare’s Health...
RESEARCH TRIANGLE PARK, N.C., July 23, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a global leader of innovative digital solutions for the operating room, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDAȁ...
RESEARCH TRIANGLE PARK, N.C., July 16, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient, announced that LKH-Universitätsklinikum Graz in Austria has entered into an agreement ...